🔎 Trials Near Me

ホーム › COPD › ネバダ州

ネバダ州におけるCOPDの臨床試験

ネバダ州内の拠点で、COPDに関する8件の研究が参加者を募集しています。

ネバダ州内の都市

公式研究テキスト（英語）

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Excel Clinical Research - Las Vegas- Site Number : 8400070, Las Vegas
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Henderson Clinical Trials- Site Number : 8400026, Henderson
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Las Vegas
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Henderson Clinical Trials, Henderson
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Las Vegas
  • Research Site, Las Vegas
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Henderson
  • GSK Investigational Site, Las Vegas
  • GSK Investigational Site, Reno
被験者募集中第3相
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Las Vegas
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Renown Regional Medical Center, Reno
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。